| 000 | 01736 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516140147.0 | ||
| 264 | 0 | _c20131223 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a2737-5935 | ||
| 024 | 7 |
_a10.11622/smedj.2013031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPadhy, Biswa Mohan | |
| 245 | 0 | 0 |
_aHypolipidaemic and anti-inflammatory effects of fixed dose combination of atorvastatin plus ezetimibe in Indian patients with dyslipidaemia. _h[electronic resource] |
| 260 |
_bSingapore medical journal _cFeb 2013 |
||
| 300 |
_a90-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aAzetidines _xadministration & dosage |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 |
_aDyslipidemias _xdrug therapy |
| 650 | 0 | 4 | _aEzetimibe |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeptanoic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aIndia |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aYadav, Rakesh | |
| 700 | 1 | _aGupta, Yogendra Kumar | |
| 773 | 0 |
_tSingapore medical journal _gvol. 54 _gno. 2 _gp. 90-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.11622/smedj.2013031 _zAvailable from publisher's website |
| 999 |
_c22555365 _d22555365 |
||